- Quality Assurance specialists
- Clinical research specialists
- CRAs
- Sponsors
- Regulatory Affairs professionals
- Clinical Investigators
- Monitors
Over the past few years there is a dramatic change in the complexity of Clinical Trials and Monitoring of Clinical Trials is still one of the most cardinal approaches in the Pharma Industry. But on-site monitoring can be a quite costly option for its effectiveness, creating a demand in the sector for a more efficient process – Risk-Based Monitoring. Embracing a real-time overview of data in combination with excellently-established risk detection and mitigation tactics, results in the most efficacious technique for handling a clinical programme.